HCAT vs HSTM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 19, 2026

HCAT

48.3
AI Score
VS
HCAT Wins

HSTM

40.5
AI Score

Investment Advisor Scores

HCAT

48score
Recommendation
HOLD

HSTM

41score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HCAT HSTM Winner
Revenue 141.24M 164.94M HSTM
Net Income -151.56M 12.58M HSTM
Net Margin -107.3% 7.6% HSTM
Operating Income -142.96M 15.83M HSTM
ROE -150.3% 3.5% HSTM
ROA -42.3% 2.4% HSTM
Total Assets 358.60M 521.60M HSTM
Cash 60.59M 46.17M HCAT
Current Ratio 2.70 1.06 HCAT
Free Cash Flow 18.10M 38.92M HSTM

Relative Price Performance (Last 90 Days)

HCAT 1M: -7.9% · 3M: -13.4% HSTM 1M: +15.5% · 3M: +27.0%

Current Technical Phase

HCAT

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -7.8%) with fading momentum, RSI 48

RSI (14): 48.2 · Price: $1.74

HSTM

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.0% over 20 days), RSI 70

RSI (14): 70.4 · Price: $33.51

Fundamentals Snapshot

Metric HCAT HSTM
Market Cap — —
Forward P/E 232.0 37.9
Trailing P/E — 46.9
Revenue (TTM) — —
Revenue Growth -0.1% 0.1%
Gross Margin 0.5% 0.7%
Operating Margin -0.1% 0.1%
EPS -3.69 0.72
Dividend Yield — 0.00%

Frequently Asked Questions

Based on our detailed analysis, HCAT is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.